A non-surgical solution for Degenerative Disc Disease

Intralink-Spine Inc. (ILS) is a company formed to develop, manufacture, and bring to market a revolutionary nonsurgical treatment  for Degenerative Disc Disease (DDD) and the associated problem of low back pain.  Our proprietary technology, NEXT (Nonsurgical EXogenous crosslink Therapy), is engineered to reduce disc bulge under load and significantly strengthen disc tissue, increasing its durability and tear resistance for immediate and long term treatment  of DDD and its associated pathologies including Spinal Stenosis, Herniated Disks, Post-Surgical Syndromes and Back Pain.  These problems affect over 15 million people each year in the US alone.  NEXT uses a tissue revitalization reagent that can be injected into the spinal disc to mechanically reinforce and stabilize the joint and decompress the surrounding neural tissues without the need for invasive spinal surgery. NEXT is based on the body’s own natural response to repair instability and degradation of the spinal disc. The NEXT device instantly and directly strengthens and stabilizes the disc, reducing the pain of the patient without the costs and risks associated with surgery.